Delta Financial Group Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 83.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,503 shares of the healthcare conglomerate’s stock after purchasing an additional 683 shares during the period. Delta Financial Group Inc.’s holdings in UnitedHealth Group were worth $723,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Chelsea Counsel Co. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $27,000. 25 LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $28,000. Cascade Investment Advisors Inc. acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $28,000. Freedom Wealth Alliance LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $31,000. Finally, Kalos Management Inc. acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $34,000. Institutional investors own 85.69% of the company’s stock.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the sale, the chief executive officer now owns 78,573 shares in the company, valued at $39,772,866.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.35% of the company’s stock.
UnitedHealth Group Stock Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.92 by $0.22. The business had revenue of $92.90 billion for the quarter, compared to analysts’ expectations of $90.97 billion. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The firm’s quarterly revenue was up 15.6% compared to the same quarter last year. During the same period last year, the firm posted $5.57 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 33.65%.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on UNH shares. Sanford C. Bernstein upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their target price for the company from $595.00 to $603.00 in a research note on Tuesday, July 18th. UBS Group raised their target price on shares of UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a research note on Wednesday, July 19th. Mizuho lowered their price target on shares of UnitedHealth Group from $600.00 to $549.00 in a report on Tuesday, July 11th. Stephens reissued an “overweight” rating and issued a $560.00 price target on shares of UnitedHealth Group in a report on Friday, August 11th. Finally, JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a report on Monday, July 17th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $575.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- What is the S&P/TSX Index?
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- How to Capture the Benefits of Dividend Increases
- MarketBeat Week in Review – 9/11 – 9/15
- What’s a Sound Playbook for Investors During Election Years?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.